Protection of cattle and swine against foot-and-mouth disease, using biosynthetic peptide vaccines

Donald O. Morgan From the USDA, Agricultural Research Services, Plum Island Animal Disease Center (PIADC), Molecular Biology Section, PO Box 848, Greenport, NY 11944.

Search for other papers by Donald O. Morgan in
Current site
Google Scholar
PubMed
Close
 DVM, PhD
and
Douglas M. Moore From the USDA, Agricultural Research Services, Plum Island Animal Disease Center (PIADC), Molecular Biology Section, PO Box 848, Greenport, NY 11944.

Search for other papers by Douglas M. Moore in
Current site
Google Scholar
PubMed
Close
 PhD

SUMMARY

A single dose of foot-and-mouth disease (fmd) virus protein 1 (vp1) peptide, expressed in Escherichia coli as a fusion protein with 190 amino acids (aa) of the LE' protein of the tryptophan operon of E coli, elicited an immune response in steers sufficient to withstand the challenge of exposure to animals with acute fmd. The 58-μg dose of viral peptide, composed of a segment of the vp1 from the A12 strain (A12) of FMD virus (fmdv; A1232dimer) in a tandem repeat configuration of aa137 through 168 and emulsified with oil adjuvant, elicited a serologic response in cattle equivalent to that obtained using conventional whole virus vaccines. Two groups of swine were vaccinated, 1 with the A12-32dimer as used in cattle and 1 with aa131 through 157 from vp1 of the A24 strain (A24) of fmdv (A24-peptide), expressed in the same system as A12-32dimer, but as a single copy per molecule. In swine, the 58-μg dose of the A12-32dimer repeated at 28 days was an effective immunogen; all swine were protected against A12 and, in addition, the vaccine protected 50% of the swine against A24. The 29-μg dose of A24-peptide, administered according to the same schedule, elicited protection against A24 in 50% of the vaccinates and, in addition, protected 25% of those vaccinates against A12. The serologic response elicited by A12-32dimer against A24 virus was considerably greater than the response elicited by A24-peptide against A12 virus. The evidence of multiple immunogenic epitopes between aa131 and aa168 was evaluated.

SUMMARY

A single dose of foot-and-mouth disease (fmd) virus protein 1 (vp1) peptide, expressed in Escherichia coli as a fusion protein with 190 amino acids (aa) of the LE' protein of the tryptophan operon of E coli, elicited an immune response in steers sufficient to withstand the challenge of exposure to animals with acute fmd. The 58-μg dose of viral peptide, composed of a segment of the vp1 from the A12 strain (A12) of FMD virus (fmdv; A1232dimer) in a tandem repeat configuration of aa137 through 168 and emulsified with oil adjuvant, elicited a serologic response in cattle equivalent to that obtained using conventional whole virus vaccines. Two groups of swine were vaccinated, 1 with the A12-32dimer as used in cattle and 1 with aa131 through 157 from vp1 of the A24 strain (A24) of fmdv (A24-peptide), expressed in the same system as A12-32dimer, but as a single copy per molecule. In swine, the 58-μg dose of the A12-32dimer repeated at 28 days was an effective immunogen; all swine were protected against A12 and, in addition, the vaccine protected 50% of the swine against A24. The 29-μg dose of A24-peptide, administered according to the same schedule, elicited protection against A24 in 50% of the vaccinates and, in addition, protected 25% of those vaccinates against A12. The serologic response elicited by A12-32dimer against A24 virus was considerably greater than the response elicited by A24-peptide against A12 virus. The evidence of multiple immunogenic epitopes between aa131 and aa168 was evaluated.

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 6846 6829 1193
PDF Downloads 67 61 9
Advertisement